Polar Capital’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $17.8M | Buy |
157,762
+59,684
| +61% | +$6.72M | 0.13% | 142 |
|
|
2020
Q2 | $9.34M | Buy |
98,078
+23,078
| +31% | +$2.2M | 0.08% | 178 |
|
|
2020
Q1 | $6.74M | Buy |
+75,000
| New | +$6.74M | 0.07% | 189 |
|
|
2018
Q3 | – | Sell |
-324,185
| Closed | -$15.7K | – | 289 |
|
|
2018
Q2 | $15.7K | Sell |
324,185
-748,713
| -70% | -$36.3K | 0.09% | 170 |
|
|
2018
Q1 | $42M | Buy |
1,072,898
+42,898
| +4% | +$1.68M | 0.42% | 77 |
|
|
2017
Q4 | $43.7M | Sell |
1,030,000
-35,000
| -3% | -$1.49M | 0.45% | 62 |
|
|
2017
Q3 | $39.7M | Sell |
1,065,000
-10,000
| -0.9% | -$373K | 0.45% | 68 |
|
|
2017
Q2 | $32.7M | Buy |
1,075,000
+325,000
| +43% | +$9.88M | 0.44% | 79 |
|
|
2017
Q1 | $19.9M | Buy |
750,000
+212,412
| +40% | +$5.62M | 0.3% | 111 |
|
|
2016
Q4 | $13.7M | Buy |
+537,588
| New | +$13.7M | 0.22% | 130 |
|
|
2015
Q2 | – | Sell |
-14,049
| Closed | -$535K | – | 309 |
|
|
2015
Q1 | $535K | Buy |
+14,049
| New | +$535K | 0.01% | 268 |
|